NCT07530666 2026-04-15Study of the Safety and Efficacy of DS010 in Patients With Cancer CachexiaDartsbio Pharmaceuticals Ltd.Phase 1/2 Not yet recruiting58 enrolled
NCT00933361 2017-08-01Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II StudyCantonal Hospital of St. GallenPhase 1/2 Completed21 enrolled